November 1, 2007 - CMS, a radiation treatment planning and workflow management solutions company, showcased its next-generation, FDA cleared Monaco IMRT planning system at ASTRO 2007.
The system, which in addition to a conventional dose-based optimization platform, offers a biological model for more accurate and precise planning to account for tissue and volume-specific dose tolerances.
Monaco’s biological optimization model is designed to define the shape of the optimum dose distribution in normal tissues. The platform also provides a sensitivity analysis tool package and custom templates to reduce planning times. Other features include Monte Carlo and pencil beam dose algorithms; Smart Sequencing; constrained optimization with optional multicriterial solutions to limit dose delivery to affected organs; and Voxel definition controls.
In addition, the system is equipped with image fusion, contouring, simulation and plan review features.
CMS also featured its works-in-progress Focal 4D, a new set of 4D visualization and contouring tools specifically designed to support 4D data sets and the requirements of 4D planning.
For more information: www.cms-euro.com
June 19, 2024 
